Trial intelligence / Profile preview

Methods to Minimize Blood Loss During Laparoscopic Myomectomy

NCT06566352Recruiting

Sponsor
Zagazig University
Start
May 2024
Primary completion
May 2025
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Randomised trial of epinephrine in Uterine Fibroids (UF) (3 arms), sponsored by Zagazig University. Primary endpoint: blood loss. Started May 2024; status: recruiting.

02

Drugs

epinephrine
03

Conditions

Uterine Fibroids (UF)

Beyond the preview

Go deeper on NCT06566352.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06566352.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call